Steven Chmura to Antiparkinson Agents
This is a "connection" page, showing publications Steven Chmura has written about Antiparkinson Agents.
Connection Strength
0.044
-
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol. 2020 04 01; 38(10):1019-1029.
Score: 0.044